The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patients with metastatic castration-resistant prostate cancer (mCRPC) who are long-term responders (LTR) to the new agent (NA)-based second line: Clinical outcomes and prognostic factors of subsequent treatment with another NA.
 
Orazio Caffo
Consulting or Advisory Role - Astellas Oncology; Bayer; Janssen; Sanofi
 
Emilio Bria
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Helsinn Healthcare; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche
 
Ugo De Giorgi
Consulting or Advisory Role - Astellas Oncology; Janssen; Sanofi
 
Marcello Tucci
Consulting or Advisory Role - Astellas Oncology; Bayer; Janssen; Sanofi
 
Elisa Biasco
No Relationships to Disclose
 
Lucia Fratino
No Relationships to Disclose
 
Sabrina Rossetti
No Relationships to Disclose
 
Roberto Iacovelli
No Relationships to Disclose
 
Claudia Mucciarini
No Relationships to Disclose
 
Paolo Andrea Zucali
No Relationships to Disclose
 
Giovanni Vicario
No Relationships to Disclose
 
Francesco Carrozza
No Relationships to Disclose
 
Zuzana Sirotova
No Relationships to Disclose
 
Caterina Messina
No Relationships to Disclose
 
Placido Amadio
No Relationships to Disclose
 
Antonio Maestri
No Relationships to Disclose
 
Cosimo Sacco
No Relationships to Disclose
 
Antonello Veccia
No Relationships to Disclose
 
Isabella Sperduti
No Relationships to Disclose
 
Vittorina Zagonel
No Relationships to Disclose